Chest
-
BronchiectasisSESSION TYPE: Slide PresentationsPRESENTED ON: Saturday, March 22, 2014 at 09:00 AM - 10:00 AMPURPOSE: To assess the effectiveness of inhaled colistin in elderly patients with bronchiectasis and chronic bronchial PA infection in reducing hospital readmissions ⋯ The following authors have nothing to disclose: Eva Tabernero, Pilar Gil, Ramon Alkiza, Javier Garros, Anibal Hernandez, Juan Luis ArtolaNo Product/Research Disclosure Information.
-
PediatricsSESSION TYPE: Slide PresentationsPRESENTED ON: Sunday, March 23, 2014 at 12:15 PM - 01:15 PMPURPOSE: The primary objective of our study is to identify the most common abnormalities of pulmonary function testing (PFT) in a pediatric non-asthmatic obese cohort. We aim to determine a possible correlation between the degree of PFT abnormalities and the severity of obesity. ⋯ The following authors have nothing to disclose: Angela Webb, Roopa Saddaiah, Claudia Halaby, Christina Valsamis, Shahidul Islam, Melodi PirzadaNo Product/Research Disclosure Information.
-
Late Breaking AbstractsSESSION TYPE: Slide PresentationPRESENTED ON: Saturday, March 22, 2014 at 09:00 AM - 10:00 AMPURPOSE: Within 2 weeks in Nov 2013, there were 8 pediatric cases of complicated pneumonia admitted to 6 pediatric ICU in Hong Kong, resulting in 2 deaths associated with hemolytic uremic syndrome. This outbreak led to this description study of the changing epidemiology of complicated pneumonia and associated hemolytic uremic syndrome in children. ⋯ The following authors have nothing to disclose: Gary Wong, Ting Leung, Chante NgNo Product/Research Disclosure Information.
-
Cardiovascular Case Report Posters IISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Carfilzomib is a novel chemotherapy agent for the treatment of relapsed and refractory Multiple Myeloma (MM). It is a selective, irreversible proteasome inhibitor that induces apoptosis of myeloma cells. It was approved by US-FDA in July 2012. ⋯ The following authors have nothing to disclose: Sameer Chadha, Rahul Yadav, Kunal Teli, Guy Kulbak, Gerald Hollander, Jacob ShaniNo Product/Research Disclosure Information.
-
OSA & COPD PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: OSAS is an independent risk factor for asthma exacerbations and OSAS symptoms are more common in asthmatic patients than in the general population. This study correlates number of exacerbations with AHI in 24 stable asthmatics with overlap of OSAMETHODS: 24 stable patients' of BA with overlap of OSA diagnosed on PSG, using or not using CPAP, attending outpatient clinic of Metro Centre for Respiratory diseases were retrospectively analysed for number of exacerbations in last one year using SPSS software. ⋯ The following authors have nothing to disclose: Mayuri Johari, Karn Mehra, Deepak TalwarNo Product/Research Disclosure Information.